Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India

• Main Authors: Nijalingappa K. Kalappanavar (Author), Apurba Ghosh (Author), Monika Sharma (Author), Latha Ravichandran (Author), Nirmal Choraria (Author), Saravanan P (Author), Madhukar Pandey (Author), Pradeep N (Author), Prachee Shah (Author), Sneha Nair (Author), Ashfaque Shaikh (Author), Serge van de Witte (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Efficacy and safety data on quadrivalent influenza vaccines (QIVs) for immunization of Indian children are scarce. This phase 3, registration study evaluated the immunogenicity, safety, and tolerability of a QIV in Indian children aged 6-35 months (Group 1) and 3-17 y (Group 2). Subjects received on...